Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Roderick Wong
When 10,000 doctors stood up and cheered for a cancer drug — America's innovation machine made it possible Original
You might have seen, in early June, more than 10,000 oncologists and drug developers gave a standing ovation mid-presentation. The slide that moved the room showed survival curves for Revolution Medicine’s daraxonrasib. For the first time, a drug showed a path to beating pancreatic cancer, nearly doubling survival. Thanks to social media, millions more shared that moment. Over the last half-dozen years of my 25-year career in biotech, I’ve enjoyed more and more moments like this.
Form 4 Orchestra BioMed Holding For: Apr 27 Filed by: RTW INVESTMENTS, LP
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). 1. Name and Address of Reporting Person * 2. Issuer Name and Ticker or Trading Symbol Orchestra BioMed Holdings, Inc.
Form 4 Kailera Therapeutics, For: Apr 20 Filed by: RTW INVESTMENTS, LP
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). 1. Name and Address of Reporting Person * 2. Issuer Name and Ticker or Trading Symbol Kailera Therapeutics, Inc.
Large owner Rtw Investments, Lp bought $149,201 worth of shares (49,900 units at $2.99) (SEC Form 4)
Orchestra BioMed's Virtue® Sirolimus AngioInfusion Balloon™ ("Virtue SAB") is the only non-coated drug-eluting balloon system under clinical investigation worldwide and has been awarded multiple FDA Breakthrough Device DesignationsThe Virtue Trial will be the first U.S. IDE head-to-head randomized evaluation of a sirolimus-eluting balloon versus a commercially available paclitaxel-coated balloon (AGENT™) for the treatment of coronary in-stent restenosis ("ISR")Robust non-inferiority trial is...
Large owner Rtw Investments, Lp bought $126,500 worth of shares (50,000 units at $2.53) (SEC Form 4)
Orchestra BioMed's Virtue® Sirolimus AngioInfusion Balloon™ ("Virtue SAB") is the only non-coated drug-eluting balloon system under clinical investigation worldwide and has been awarded multiple FDA Breakthrough Device DesignationsThe Virtue Trial will be the first U.S. IDE head-to-head randomized evaluation of a sirolimus-eluting balloon versus a commercially available paclitaxel-coated balloon (AGENT™) for the treatment of coronary in-stent restenosis ("ISR")Robust non-inferiority trial is...
Form 3 ALLURION TECHNOLOGIES, For: Jan 14 Filed by: WONG RODERICK
These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.
Form 4 CARGO Therapeutics, Inc. For: Jan 12 Filed by: RTW INVESTMENTS, LP
Tweet Share E-mail 0 shares FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 OMB APPROVAL OMB Number: 3235-0287 Expires: December 31, 2014 Estimated average burden hours per response: 0.5 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.
Form 4 ROCKET PHARMACEUTICALS, For: Aug 28 Filed by: RTW INVESTMENTS, LP
Tweet Share E-mail 0 shares FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 OMB APPROVAL OMB Number: 3235-0287 Expires: December 31, 2014 Estimated average burden hours per response: 0.5 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.
Statement of changes in beneficial ownership of securities
Form 4 - Statement of changes in beneficial ownership of securities August 30 2023 - 04:15PM Edgar (US Regulatory) SEC Form 4 FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5 Check this box if no longer subject...
Statement of Changes in Beneficial Ownership (4)
Statement of Changes in Beneficial Ownership (4) May 05 2023 - 08:11AM Edgar (US Regulatory) FORM 4 ☐ Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response...
Form 4 Renovacor, Inc. For: Dec 01 Filed by: RTW INVESTMENTS, LP
Form 4 Renovacor, Inc. For: Dec 01 Filed by: RTW INVESTMENTS, LP April 5, 2023 4:31 PM EDT Tweet Share E-mail News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.
Form 4 Milestone Pharmaceutical For: Mar 22 Filed by: RTW INVESTMENTS, LP
Form 4 Milestone Pharmaceutical For: Mar 22 Filed by: RTW INVESTMENTS, LP March 24, 2023 4:31 PM EDT Tweet Share E-mail Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.
Form 4 Orchestra BioMed Holding For: Jan 26 Filed by: RTW INVESTMENTS, LP
Form 4 Orchestra BioMed Holding For: Jan 26 Filed by: RTW INVESTMENTS, LP January 30, 2023 5:12 PM EST Tweet Share E-mail News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.
Form 3 Health Sciences Acquisit For: Jan 24 Filed by: RTW INVESTMENTS, LP
Form 3 Health Sciences Acquisit For: Jan 24 Filed by: RTW INVESTMENTS, LP January 26, 2023 5:22 PM EST Tweet Share E-mail Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Roderick
Contact Roderick, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack